Location: Home
  • search
  • go
  • Relate News
  • 2/1/2023NH Reports on Chinese OTC Sleep Aids Market in MAT 09/2022
  • 2/1/2023NH Reports on Chinese OTC Eye Care Market in MAT 09/2022
  • 1/26/2023Prospects for European Companies in China in 2023
  • 1/24/2023China's Drug-Pricing Policy Impedes Biotech Profits (Financial Times)
  • 1/18/2023China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...
  • 1/16/2023The China Imperative for Multinational Companies
  • 1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022
  • 1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
  • 1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
  • 1/12/2023MNC Incubators in China (PharmaDJ)
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 12/30/2022Abbott to Exit China's Pediatric Nutrition Market
  • 12/5/2022Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
  • 11/24/2022IQVIA: Chinese Hospital Drug Market Steady in MAT Q3/2022
  • 11/23/2022GlobalData: Chinese Manufacturers' Transition to Innovative Pharma Req...
  • 11/21/2022Performance of A Share-listed MedPharm Cos Improved in Q3/2022
  • 11/15/2022NMPA Holds Conference on Promotion of Foreign Trade and Investment
  • 11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022
  • 11/10/2022AstraZeneca Reports Strong Quarterly Results with China Growth Despite...
  • 11/10/2022China's Biopharma Industry: Market Prospects, Investment Paths (China ...
  • 11/10/2022Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...
  • 11/6/2022Germany Pharma CEOs Visit China with German Chancellor Scholz
  • 10/19/2022GSK to Focus on Innovative Medicines and Vaccines to Drive Growth in C...
  • 10/18/2022China's Party Congress Promises Continuity, Not Change (AP)
  • 10/18/2022Xi's Work Report to the 20th Party Congress: 5 Takeaways (The Diplomat...
  • 10/16/2022SMEI: Chinese Terminal Drug Market Growth Slowed to 1.7% in H1/2022
  • 10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)
  • 10/2/2022NH Reports MAT H1/2022 Data on the Chinese Cough, Cold and Allergy Mar...
  • 9/28/2022China's Focus to Develop Domestic Medical Device Industry May Discoura...
  • 9/28/2022MNCs Witnessed China Performance Slump in Q2/2022
  • Page:9/39 Total number of articles:1164: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group